Psycho-vegetative and somatic associations in patients with coronary heart disease
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
This literature review is focused on psycho-emotional status in patients with various clinical forms of coronary heart disease (CHD), as well as the specifics of autonomic regulation and clinical course, including CHD prognosis. The authors describe selected methods for objective dynamic assessment of these characteristics and their interrelations.
About the Authors
T. A. LimanRussian Federation
Tver
V. F. Vinogradov
Russian Federation
Tver
D. V. Alexeev
Russian Federation
Tver
A. S. Kachalova
Russian Federation
Tver
R. A. Razygraev
Russian Federation
Tver
References
1. Vasyuk Yu.A., Dovzhenko T.V. Depressiya i serdechno-sosudistye zabolevaniya. Moskva 2005; 24 str.
2. Vegetativnye rasstroistva: klinika, lechenie, diagnostika. Pod red. A. M. Veina M. Meditsinskoe inform agent-vo 2003; 752 s.
3. Vinogradov V.F. Khronicheskaya IBS u bol'nykh s psikho-vegetativnymi narusheniyami. Diss dokt med nauk. Tver' 1991; 344 s.
4. Zhuk B.C. Variabel'nost' serdechnogo ritma pri vegetativnykh probakh u bol'nykh infarktom miokarda i ee prognosticheskoe znachenie dlya vnezapnoi serdechnoi smerti. Ul'trazvuk funkts diagn 2002; 4: 102-7.
5. Kachkovskii M.A., Kryukov H.H. Lechenie depressii u bol'nykh infarktom miokarda tianeptinom. Kardiologiya 2006; (5): 21-6.
6. Kornetov H.A., Lebedeva E.V. Depressivnye rasstroistva u patsientov, perenesshikh infarkt miokarda. Psikhiatr psikhofarmakoter 2003; 5(5):195-8.
7. Ovsyannikov C.A., Tsygankov B.D. Psikhiatriya. Osnovy klinicheskoi psikhopatologii. M.: Meditsina 2007; 335 s.
8. Oganov R.G., Pogosova G.V., Shal'nova S.A., Deev A.D. Rezul'taty issledovaniya “KOMPAS”. Kardiologiya 2005; 8: 37-43.
9. Pogosova G.V. Depressiya - novyi faktor riska ishemicheskoi bolezni serdtsa i prediktor koronarnoi smerti. Kardiologiya 2002, 4: 86-91.
10. Popov V.V. Kompleksnyi podkhod k otsenke elektricheskoi nestabil'nosti miokarda u bol'nykh ishemicheskoi bolezn'yu serdtsa. RKZh 2006; 4: 83-90.
11. Syromyatnikova L.I., Shestakov V.V., Zubarev M.A. Osobennosti depressivnykh narushenii u bol'nykh s OIM. Materialy simpoziuma “Psikhovegetativnye sindromy u terapevticheskikh bol'nykh” XII Rossiiskogo natsional'nogo kongressa “Chelovek i lekarstvo”. Moskva 2000; 18-22.
12. Bonnemeier H, Hartmann F, Wiegand UKH, et al. Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. JACC 2001; 37: 44-50.
13. Bruce EC, Musselman DL. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005; 67 Suppl 1: 34-6.
14. Brundtland GH. Mental health in the 21st century. Bulletin of the World Health Organization 2000; 78: 411.
15. Bush DE, Ziegelstein RS, Patel UV, et al. Post-myocardial infarction depression. Evidence Report/Technology Assessment No. 123. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-02-0018.) AHRQ Publication No. 05-E018-2. Rockville, MD: Agency for Healthcare Research and Quality. May 2005.
16. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 8: 337-41.
17. Carney RM, Freedland KE, Sheps DS. Depression is a risk factor for mortality in coronary heart disease. Psychosom Med 2004; 66: 799-801.
18. Carney RM, Freedland KE, Stein PK, et al. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000; 62: 639-47.
19. Carney RM, Freedland KE, Stein PhK, et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med 2003; 65: 177-80.
20. Carney RM, Freedland KE, Veith RC, et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999; 45: 458-63.
21. Carney RM, Rich MW, de Velde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60: 1273-7.
22. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
23. Frasure-Smith N, Lesperans F, Talajic M. Depression and 18 month prognosis after miocardial infarction. Circulation 1995; 91: 999-1005.
24. Gillespie ChF, Nemeroff ChB. Hypercortisolemia and depression. Psychosom Med 2005; 67 Suppl 1: 26-8.
25. Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression: relation to neurocircuity and somatic consequences. Proc Assoc Am Physicians 1999; 111: 22-34.
26. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Circulation 1996; 93:1043-65.
27. Herbert TE, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993; 113: 472-86.
28. Horsten M, Mittleman MA, Wamala SP, et al. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. Eur Heart J 2000; 21: 1072-80.
29. Kleiger RE, Miller JP, Bigger JTJr, Moss AJ. Decreased heart rate variability and its association with mortality after myocardial infarction. Am J Cardiol 1987; 113: 256-62.
30. Lane D, Carroll D, Ring Ch, et al. Mortality and quality of life 12 Months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221-30.
31. Lane D, Carroll D, Ring Ch, et al. In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. Int J Epidemiol 2002; 31: 1179-82.
32. Lauzon S, Beck SA, Huynh T, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 2003; 168 (5): 547-52.
33. Mayou RA, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-9.
34. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987; 75: 131-8.
35. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55: 580-92.
36. Nakatani D, Sato H, Sakata Y, et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150: 652-8.
37. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11: 19-27.
38. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular diseasefree people; the ATTICA study. Eur Heart J 2004; 6: 492-9.
39. Pitzalis MV, lacoviello M, Todarello O, et al. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 2001; 141: 765-71.
40. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21: 293-307.
41. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990; 82: 103-10.
42. Rosengren A, Hauken S. Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTER-HEART study): casecontrol study, www.thelancet.com. September 3, 2004.
43. Roy A, Pickar D, De Jong J, et al. Norepinephrine and its metabolites in cerebrospinal fluid, plasma and urine: relationship to hypothalamicpituitary-adrenal axis function in depression. Arch Gen Psychiatry 1988; 45: 849-57.
44. Sheps DS, Rozansky A. From feeling blue to clinical depression: exploring the pathogenicity of depressive symptoms and their management in cardiac practice. Psychosom Med 2005; 67 Suppl 1: 2-5.
45. Stewart RAH, North FM, West TM, et al. Depression and cardiovascular morbidity and mortality: cause or consequence? Eur Heart J 2003; 24: 2027-37.
46. Strik JJ, Lousberg R, Cheriex EC, Honig A. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome, J Psychosom Res 2004; 56: 59- 66.
47. Suarez EC. C-Reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 2004; 66: 684-91.
48. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814-22.
49. van Melle JP, de Jonge P, Ormel J, et al. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J 2005; 26: 2650-6.
50. Vigo DE, Siri LN, Ladron de Guevara S, et al. Relation of depression to heart rate nonlinear dynamics in patients >60 years of age with recent unstable angina pectoris or acute myocardial infarction. Am J Cardiol 2004; 93: 756-60.
51. Wittstein IS, Thiemann DR, Lima JAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352: 539-48.
52. Young EA, Haskett RF, Murphy-Weinberg V, et al. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991; 48: 693-9.
Review
For citations:
Liman T.A., Vinogradov V.F., Alexeev D.V., Kachalova A.S., Razygraev R.A. Psycho-vegetative and somatic associations in patients with coronary heart disease. Cardiovascular Therapy and Prevention. 2011;10(7):105-109. (In Russ.)
ISSN 2619-0125 (Online)